Metaclipse Therapeutics Awarded Funding from NIAID for COVID-19 Vaccine Development ATLANTA, July 20, 2020 (GLOBE NEWSWIRE) -- Metaclipse, a late-stage biotechnology company developing next-generation vaccines with a particular focus on treatments for the elderly, has been awarded...